Sönmez, EmineSönmez, Ali SuhaBayındır, YaşarCoşkun, DilerAriturk, Sedat2019-06-272019-06-272002100264-410X0264-410Xhttps://hdl.handle.net/20.500.12469/201https://doi.org/10.1016/S0264-410X(02)00452-8In this prospective study our aim was to test the effect of simultaneous administration of preS2 and S containing recombinant hepatitis B vaccine (S2SRHB) with tetanus toxoid (TT) to the individuals who did not respond after three doses of hepatitis B vaccine previously. There were three groups (healthy individuals pregnant women hemodialysis patients) each was divided into two subgroups as groups A and B. Group A received S2SRHB + TT and group B received only S2SRHB. We found that in groups receiving both vaccines both seroconversion rate and antibody titer level were significantly higher (P < 0.05). In conclusion simultaneous administration of S2SRHB + TT is more effective than administration of S2SRHB alone. (C) 2002 Elsevier Science Ltd. All rights reserved.eninfo:eu-repo/semantics/openAccessHepatitis B vaccineTetanus toxoidNonresponderArticle24324621WOS:00017972390001210.1016/S0264-410X(02)00452-82-s2.0-0037073575Q3Q112450699